← board
BSPK
distress 6/10 · elevated risk$0.100%today-69% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.1 yrs
Shares 1y
+1%
Price & events
-60.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-13.3%
1W
-34.4%
1M
-56.2%
3M
-60.0%
6M
-45.9%
1Y
+35.2%
2Y
-89.1%
5Y
-89.4%
All
Overview
- Market Cap
- $1.13M
- Volume
- 0
- 52 Week Range
- $0.10 – $0.32
- Total Shares
- 11.25M
- Float Shares
- 7.74M
- % Held by Insiders
- 22.26%
- % Held by Institutions
- 9.02%
- Beta
- 0.07
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.